Common prostate cancer test failing to diagnose most aggressive cancers, study finds
A widely used test to detect prostate cancer has a small impact on reducing deaths and misses early detection of some aggressive cancers, new research has found.
More than 400,000 men aged between 50 and 69 were involved in the largest study of its kind carried out by researchers from the universities of Bristol, Oxford and Cambridge.
The trial tested the effect of-Specific Antigen () , which is with urinary symptoms for further checks.
